Vimta Labs Ltd Performance
Day's Low
Day's High
₹950.55Day's Price Range₹1,013.252 Week's Low
52 Week's High
₹390.352-Week Price Range₹1,069.95
| Returns % | |
| 1 Month Return | + 30.81 % |
| 3 Month Return | + 75.53 % |
| 1 Year Return | + 154.13 % |
| Market Stats | |
| Previous Close | ₹1,000.25 |
| Open | ₹1,000.25 |
| Volume | 1.25L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹2,203.67Cr |
Vimta Labs Ltd Key Statistics
| P/E Ratio | 44.32 |
| PEG Ratio | 11.51 |
| Market Cap | ₹2,203.67 Cr |
| P/B Ratio | 3.12 |
| EPS | 18.5 |
| Dividend Yield | 0.45 |
| Sector | Healthcare |
| ROE | 13 |
Vimta Labs Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹2,203.67 Cr | 197.33% | 0.55 | ₹41 Cr | ₹318 Cr | |
| BUY | ₹2,516.20 Cr | 26.72% | 0.56 | ₹83 Cr | ₹933 Cr | |
| NA | ₹324.53 Cr | 1.26% | 0.50 | NA | NA | |
| NA | ₹4,596.79 Cr | 240.16% | 0.56 | NA | NA | |
| BUY | ₹30,463.18 Cr | 34.2% | 0.55 | ₹326 Cr | ₹2,694 Cr |
About Vimta Labs Ltd
Share Price: ₹961.90 per share as on 20 Dec, 2024 04:01 PM
Market Capitalisation: ₹2,203.67Cr as of today
Revenue: ₹84.74Cr as on September 2024 (Q3 24)
Net Profit: ₹15.25Cr as on September 2024 (Q3 24)
Listing date: 15 Dec, 2005
Chairperson Name: S P Vasireddi
| Organisation | Vimta Labs Ltd |
| Headquarters | |
| Industry | Healthcare |
| E-voting on shares | Click here to vote |
Key events for Vimta Labs Ltd
Vimta Labs Shares Surge on Strong Earnings - 18 Dec, 2024
Vimta Labs' shares soared 85% in six weeks, hitting a new high after Q2FY25 profits more than doubled. The company focuses on pharmaceutical services and plans to expand its new facility in Hyderabad, anticipating continued growth despite market challenges.CFO Resignation at Vimta Labs Announced - 05 Dec, 2024
Rama Narahai Naidu Dodda has resigned as Chief Financial Officer of Vimta Labs, effective December 10, to explore new career opportunities outside the company.Vimta Labs Reports Strong Q2FY25 Performance - 25 Nov, 2024
Vimta Labs shares surged 15% after reporting a 63% increase in stock value over one month. Q2FY25 PAT more than doubled to Rs 17 crore, driven by pharmaceutical services. The company divested its diagnostic services to focus on core operations, improving Ebitda margins significantly. Management anticipates continued growth in pharmaceutical and food testing services.
Insights on Vimta Labs Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTBest in 3 Years
In the last 3 years, VIMTALABS has outperformed top 5 stocks with highest market-cap in Biotechnology & Medical Research
- POSITIVE IMPACT
Retail Holding Up
Retail Investor have increased holdings from 56.46% to 59.80% in Sep 2024 quarter
- POSITIVE IMPACT
Best in 1 Year
In the last 1 year, VIMTALABS has outperformed top 5 stocks with highest market-cap in Biotechnology & Medical Research
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, 12.28 Cr → 15.25 Cr (in ₹), with an average increase of 19.5% per quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 75.57 Cr → 85.43 Cr (in ₹), with an average increase of 11.5% per quarter
- POSITIVE IMPACT
Price Rise
In the last 1 month, VIMTALABS stock has moved up by 33.6%
NO EFFECTPromoter Holding Unchanged
Promoters holdings remained unchanged at 36.89% of holdings in Sep 2024 quarter
NEGATIVE IMPACTFII Holding Down
Foreign Institutions have decreased holdings from 5.16% to 3.31% in Sep 2024 quarter
- NEGATIVE IMPACT
MF Holding Down
Mutual Funds have decreased holdings from 1.49% to 0.00% in Sep 2024 quarter
Vimta Labs Ltd Financials
Index Inclusions
Vimta Labs Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 36.89% | 0.00 | |
| Foreign Institutions | 3.31% | ||
| Mutual Funds | 0% | ||
| Retail Investors | 59.8% | 5.91 | |
| Others | 0% | 0.00 |
Vimta Labs Ltd Key Indicators
Vimta Labs Ltd Valuation
Vimta Labs Ltd in the last 5 years
Lowest (13.76x)
March 20, 2023
Today (44.32x)
December 19, 2024
Industry (105.00x)
December 19, 2024
Highest (44.32x)
December 19, 2024
Vimta Labs Ltd Earnings and Dividends
Vimta Labs Ltd Earnings Results
Vimta Labs Ltd’s net profit jumped 140.92% since last year same period to ₹15.25Cr in the Q2 2024-2025. On a quarterly growth basis, Vimta Labs Ltd has generated 24.19% jump in its net profits since last 3-months.
Read More about Earnings ResultsVimta Labs Ltd Dividends May,2024
In the quarter ending March 2024, Vimta Labs Ltd has declared dividend of ₹2 - translating a dividend yield of 0.21%.
Read More about Dividends
Vimta Labs Ltd Technicals Summary
Bearish
Neutral
Bullish
Vimta Labs Ltd is currently in a Bullish trading position according to technical analysis indicators.
FAQs on Vimta Labs Ltd
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Vimta Labs Ltd shares.
Vimta Labs Ltd (VIMTALABS) share price today is ₹961.9
Vimta Labs Ltd is listed on NSE
Vimta Labs Ltd is listed on BSE
- Today’s highest price of Vimta Labs Ltd is ₹1013.2.
- Today’s lowest price of Vimta Labs Ltd is ₹950.55.
PE Ratio of Vimta Labs Ltd is 44.32
PE ratio = Vimta Labs Ltd Market price per share / Vimta Labs Ltd Earnings per share
Today’s traded volume of Vimta Labs Ltd(VIMTALABS) is 1.25L.
Today’s market capitalisation of Vimta Labs Ltd(VIMTALABS) is ₹2203.67Cr.
| Vimta Labs Ltd(VIMTALABS | Price |
|---|---|
52 Week High | ₹1069.95 |
52 Week Low | ₹390.3 |
Vimta Labs Ltd(VIMTALABS) share price is ₹961.9. It is down -10.10% from its 52 Week High price of ₹1069.95
Vimta Labs Ltd(VIMTALABS) share price is ₹961.9. It is up 146.45% from its 52 Week Low price of ₹390.3
| Vimta Labs Ltd(VIMTALABS | Returns |
|---|---|
1 Day Returns | -38.35% |
1 Month Returns | 30.81% |
3 Month Returns | 75.53% |
1 Year Returns | 154.13% |